Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production

Neurobiology of Aging

Volumn 25, Issue 4, 2004, Pages 431-439

  Kim, Seon H ^a   Smith, Carolyn J ^a   Van Eldik, Linda J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Beta amyloid; ERK; Interleukin 1; JNK; LPS; MAP kinase; Microglia; p38; S100B

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN S100B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIA CELL; INFLAMMATION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ANIMALS; CATTLE; CELL LINE; CELLS, CULTURED; ENZYME INHIBITORS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MAP KINASE SIGNALING SYSTEM; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; RATS; S100 PROTEINS;

EID: 1542298238     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00126-X     Document Type: Article

References (77)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M.et al. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
2. Alexanian A.R., Bamburg J.R. Neuronal survival activity of S100B is enhanced by calcineurin inhibitors and requires activation of NFκB. FASEB J. 13:1999;1611-1620.
3. Baldassare J.J., Bi Y., Bellone C.J. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162(9):1999;5367-5373.
4. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23(7):2003;2665-2674.
5. Benveniste E.N. Inflammatory cytokines within the central nervous system: source, function, and mechanism of action. Am. J. Physiol. 32:1992;C1-C16.
6. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E.et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10075-10078.
7. Caivano M., Cohen P. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccaride-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J. Immunol. 164(6):2000;3018-3025.
8. Carter A.B., Monick M.M., Hunninghake G.W. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 20(4):1999;751-758.
9. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:2002;32046-32053.
10. Daniels W.M., Hendricks J., Salie R., Taljaard J.J. The role of the MAP-kinase superfamily in beta-amyloid toxicity. Metab. Brain Dis. 16(3/4):2002;175-185.
11. Das S., Potter H. Expression of Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14:1995;447-456.
12. Dineley K.T., Waterman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acethylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21:2001;4125-4133.
13. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochem. Biophys. Acta. 1450:1999;191-231.
14. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:2001;637-668.
15. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 382(6593):1996;716-719.
16. Faas M.M., Moes H., Fijen J.W., Muller Kobold A.C., Tulleken J.E., Zijlstra J.G. Monocyte intracellular cytokine production during human endotoxemia with or without a second in vitro LPS challenge: effect of RWJ-67657, a p38 MAP-kinase inhibitor, on LPS-hypo responsiveness. Clin. Exp. Immunol. 127(2):2002;337-343.
17. Giri J.G., Lomedico P.T., Mizel S.B. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J. Immunol. 134(1):1985;343-349.
18. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S.et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7606-7610.
19. Goncalves D.S., Lenz G., Karl J., Goncalves C.A., Rodnight R. Extracellular S100B protein modulates ERK in astrocyte cultures. NeuroReport. 11:2000;807-809.
20. Griffin W.S.T., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:1996;276-281.
21. Griffin W.S.T., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I.et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression. Brain Pathol. 8:1998;65-72.
22. Griffin W.S.T., Stanley L.C., Ling C., White L., McLeod W., Perrot L.J. et al. Brain interleukin 1 and S100 immuno-reactivity are elevated in Down's syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7611-7615.
23. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13(2):2001;85-94.
24. Guo L., Sawkar A., Zasadzki M., Watterson D.M., Van Eldik L.J. Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands. Neurobiol. Aging. 22:2001;975-981.
25. Haddad E.B., Birrell M., McCluskie K., Ling A., Webber S.E., Foster M.L.et al. Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. Br. J. Pharmacol. 132:2001;1715-1724.
26. Hazuda D.J., Lee J.C., Young P.R. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J. Biol. Chem. 263(17):1988;8473-8479.
27. Hazuda D.J., Strickler J., Kueppers F., Simon P.L., Young P.R. Processing of precursor interleukin 1 beta and inflammatory disease. J. Biol. Chem. 265(11):1990;6318-6322.
28. Hidding U., Mielke K., Waetzig V., Brecht S., Hanisch U., Behrens A.et al. The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. Biochem. Pharmacol. 64(5/6):2002;781-788.
29. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y.et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901.
30. Hsu H.Y., Wen M.H. Lipopolysaccaride-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277:2002;22131-22139.
31. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
32. Hu J., Van Eldik L.J. Glial-derived proteins activate cultured astrocytes and enhance beta-amyloid-induced glial activation. Brain Res. 842:1999;46-54.
33. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Co-regulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation endproducts (RAGE) activation. J. Biol. Chem. 275:2000;40096-40105.
34. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912.
35. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110(2):2002;191-202.
36. Koistinaho M., Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinase in microglia. Glia. 40:2002;175-183.
37. Kuperstein F., Yavin E. ERK activation and nuclear translocation in amyloid-beta peptide and iron-stressed neuronal cell cultures. Eur. J. Neurosci. 16:2002;44-54.
38. Lam A.G., Koppal T., Akama K.T., Guo L., Craft J.M., Samy B.et al. Mechanism of glial activation by S100B: involvement of the transcription factor NFκB. Neurobiol. Aging. 22:2001;765-772.
39. Lee J., Mira-Arbibe L., Ulevitch R.J. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccaride. J. Leukoc. Biol. 68:2000;909-915.
40. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E.et al. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155.
41. Lin Y., Lee H., Berg A.H., Lisanti M.P., Shapiro L., Scherer P.E. The lipopolysaccaride-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275(32):2000;24255-24263.
42. Lorton D., Schaller J., Lala A., De Nardin E. Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's disease. Neurobiol. Aging. 21:2000;463-473.
43. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:1998;4451-4460.
44. Mirzoeva S., Sawkar A., Zasadzki M., Guo L., Valentza A.V., Dunlap V.et al. Discovery of 3-amino-6-phenyl-pyridazune derivative as a new synthetic antineuroinflammatory compound. J. Med. Chem. 45:2002;563-566.
45. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takono H., Flavell R.et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and induction of Fas ligand. J. Neurosci. 21:2001;7551-7560.
46. Mrak R.E., Griffin W.S.T. Interleukin-1, neoroinflammation, and Alzheimer's disease. Neurobiol. Aging. 22:2001;903-908.
47. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
48. O'Barr S., Cooper N.R. The C5a complement activation peptide increases IL-1β and IL-6 release from amyloid-β primed human monocytes: implications for Alzheimer's disease. J. Neuroimmunol. 109:2000;87-94.
49. Okazawa H., Estus S. The JNK/c-Jun cascade and Alzheimer's disease. Am. J. Alzheimer's Dis. Other Demen. 17:2002;79-88.
50. Paris D., Townsend K.P., Obregon D.F., Humphrey J., Mullan M. Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat. 70:2002;1-12.
51. Peña L.A., Brecher C.W., Marshak D.R. β-Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol. Brain Res. 34:1995;118-126.
52. Peskind E.R., Griffin W.S.T., Akama K.T., Raskind M.A., Van Eldik L.J. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem. Int. 39:2001;409-413.
53. Petrova T.V., Akama K.T., Van Eldik L.J. Cyclopentanone prostaglandins suppress activation of microglia: down-regulation of inducible nitric oxide synthase by 15-deoxy-Delta-12,14-prostaglandin J2. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4668-4673.
54. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhau S.S., Potter H.et al. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274:1999;6421-6431.
55. Rubartelli A., Bajetto A., Allavena G., Cozzolino F., Sitia R. Post-translational regulation of interleukin 1 beta secretion. Cytokine. 5(2):1993;117-124.
56. Sato N., Kamino K., Tateishi K., Satph T., Nishiwaki Y., Yoshiiwa A.et al. Elevated amyloid beta protein(1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (Erk1/2)-dependent pathway in rat pheochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 232:1997;637-642.
57. Savage M.J., Lin Y.G., Ciallela J.R., Flood D.G., Scott R.W. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22:2002;3376-3385.
58. Scherle P.A., Jones E.A., Favata M.F., Daulerio A.J., Covingston M.B., Nurnberg S.A.et al. Inhibition of MAP kinase prevents cytokine and prostaglandin E2 production in lipopolysaccaride-stimulated monocytes. J. Immunol. 161:1998;5681-5686.
59. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J.et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
60. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E.et al. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem. Int. 39:2001;341-348.
61. Sheng J.G., Mrak R.E., Griffin W.S.T. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1β + microglia and S100β + astrocytes with neurofibrillary tangle stage. J. Neuropathol. Exp. Neurol. 56:1997;285-290.
62. Sheng J.G., Zhu S.G., Griffin W.S.T., Mrak R.E. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp. Neurol. 163:2000;388-391.
63. Sweet M.J., Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60(1):1996;8-26.
64. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of the cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 3:1995;437-457.
65. Valledor A.F., Comalada M., Xaus J., Celada A. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275:2000;7403-7409.
66. Van Eldik L.J., Griffin W.S.T. S100β expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
67. Van Eldik L.J., Staecker J.L., Winningham-Major F. Synthesis and expression of a gene coding for the calcium-modulated protein S100 beta and designed for cassette-based, site-directed mutagenesis. J. Biol. Chem. 263:1988;7830-7837.
68. Watters J.J., Sommer J.A., Pfeiffer Z.A., Prabhu U., Guerra A.N., Bertics P.J. A differential role for the mitogen-activated protein kinases in lipopolysaccaride signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin1 beta production. J. Biol. Chem. 277:2002;9077-9087.
69. Watterson D.M., Mirzoeva S., Guo L., Whyte A., Bourguignon J.J., Hibert M.et al. Ligand modulation of glial activation: cell permeable, small molecule inhibitors of serine-threonine protein kinase can block induction of interleukin1 beta and nitric oxide synthase II. Neurochem. Int. 39:2001;459-468.
70. Wei W., Norton D.D., Wang X., Kusiak J.W. Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain. 125:2002;2036-2043.
71. Williams B.R. Signal integration via PKR. Sci. STKE. 89:2001;RE2.
72. Willis S.A., Nisen P.D. Differential induction of the mitogen-activated protein kinase pathway by bacterial lipopolysaccaride in cultured monocytes and astrocytes. Biochem. J. 313:1996;519-524.
73. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A.et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382(6593):1996;685-691.
74. Yang H., Young D.W., Gusovsky F., Chow J.C. Cellular events mediated by lipopolysaccaride-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinase and Elk-1. J. Biol. Chem. 275(27):2000;20861-20866.
75. Yates S.L., Burgess L.H., Kocsis-Angle J., Antal J.M., Dority M.D., Embury P.B.et al. Amyloid β and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74:2000;1017-1025.
76. Yoshinari D., Takeyoshi I., Koibuchi Y., Matsummoto K., Kawashima Y., Koyoma T.et al. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit. Care Med. 29:2001;628-634.
77. Young P.R., Hazuda D.J., Simon P.L. Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. J. Cell Biol. 107(2):1988;447-452.